This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Mcmaster University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Boris Simovic
Introduction
Boris Simovic is a notable inventor based in Waterloo, Canada. He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on combining adoptive cell transfer with oncolytic virus therapy, showcasing his commitment to advancing medical science.
Latest Patents
Boris Simovic holds a patent for a groundbreaking method titled "Adoptive cell transfer and oncolytic virus combination therapy." This invention describes a method for treating cancer that involves the adoptive transfer of tumor antigen-specific CD8+ T cells alongside an oncolytic virus vaccine targeting the same antigen. This innovative approach has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Simovic is affiliated with McMaster University, where he contributes to research and development in the medical field. His work is characterized by a strong focus on cancer therapies, and he has dedicated his career to finding effective solutions for patients battling this disease.
Collaborations
Boris Simovic collaborates with esteemed colleagues such as Yonghong Wan and Scott Walsh. Their combined expertise fosters a productive research environment, leading to advancements in cancer treatment methodologies.
Conclusion
Boris Simovic's contributions to cancer treatment through his innovative patent and collaborative efforts at McMaster University highlight his dedication to improving patient outcomes. His work exemplifies the impact of innovation in the medical field.